Dr. Kathrin Lafaver, MD

Dr. Lafaver practices at Saratoga Hospital in Saratoga Springs, New York, part of Albany Med Health System.

Dr. Lafaver's NPI, 1528188836, was assigned on March 30, 2007. Dr. Lafaver holds New York license 309925.

Dr. Lafaver's primary practice is Saratoga Hospital, at 211 Church Street, Saratoga Springs, NY 12866 in Saratoga County. The practice phone is (518) 587-3222.

Dr. Lafaver's primary practice is Saratoga Hospital in Saratoga Springs, New York, part of Albany Med Health System. Dr. Lafaver is also affiliated with Albany Medical Center. The medical group on file is Albany Med EmUrgentCare. Dmand AI also links Dr. Lafaver to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lafaver practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Lafaver's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Lafaver's licenses on file in 4 states: New York, Illinois, Kentucky and Massachusetts.

CMS data shows 956 Medicare services from Dr. Lafaver across 6 procedure codes in 2024, for 393 Medicare patients. Medicare paid $44,096 for them. Every service was in an office.

CMS counts 393 Medicare patients who saw Dr. Lafaver in 2024. The largest group is 75 to 84, with 163 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lafaver's median patient age at 67, with 62% women.

In 2024, Dr. Lafaver wrote 4,136 Medicare Part D claims for 549 patients. 88% of them were for generic drugs. CMS names the drug for 3,921 of them, across 65 drugs with 11 or more claims each, at $1,056,477 in total drug cost. In 2023, CMS named 2,517 claims across 47 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 69 out of 100 for Dr. Lafaver for performance year 2024, reported as part of a group. Dr. Lafaver accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lafaver as offering telehealth.

Dmand AI links 39 papers to Dr. Lafaver, published from 2013 to 2023. 2019 was the busiest year, with 7. The most frequent topics are Movement Disorders, Conversion Disorder and Parkinson Disease. Dr. Lafaver has published most often in Parkinsonism Relat Disord. Dr. Lafaver's most frequent co-authors are Carine W. Maurer, MD, PhD, Alberto J. Espay, MD and Amy B. Hessler, DO.

Dmand AI links Dr. Lafaver to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Huntington Disease, Parkinson Disease and Chorea.

CMS Open Payments shows 112 general payments to Dr. Lafaver from 25 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $12,790.